Great Lakes Advisors LLC decreased its stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 69.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,623 shares of the company’s stock after selling 8,217 shares during the period. Great Lakes Advisors LLC’s holdings in HCA Healthcare were worth $1,087,000 at the end of the most recent quarter.
Several other hedge funds have also bought and sold shares of HCA. Whipplewood Advisors LLC acquired a new stake in HCA Healthcare in the 4th quarter valued at about $31,000. Legacy Investment Solutions LLC acquired a new stake in HCA Healthcare in the 3rd quarter valued at about $39,000. Activest Wealth Management lifted its stake in HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after purchasing an additional 125 shares during the last quarter. Pinnacle Bancorp Inc. lifted its position in HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after acquiring an additional 50 shares during the last quarter. Finally, Eastern Bank acquired a new stake in HCA Healthcare during the fourth quarter worth approximately $62,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on HCA. Cantor Fitzgerald restated an “overweight” rating and set a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. JPMorgan Chase & Co. restated a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. KeyCorp lowered their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Bank of America lowered their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. Finally, Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their target price for the stock from $400.00 to $320.00 in a report on Monday, November 25th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $385.67.
HCA Healthcare Stock Performance
NYSE HCA opened at $319.82 on Friday. The firm’s fifty day moving average price is $319.00 and its two-hundred day moving average price is $345.26. The stock has a market cap of $78.74 billion, a PE ratio of 14.56, a PEG ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the firm earned $5.90 EPS. On average, equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.
HCA Healthcare Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.90%. The ex-dividend date is Monday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s payout ratio is 13.11%.
Insider Transactions at HCA Healthcare
In related news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.60% of the stock is owned by company insiders.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Read More
- Five stocks we like better than HCA Healthcare
- Canada Bond Market Holiday: How to Invest and Trade
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- The Most Important Warren Buffett Stock for Investors: His Own
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.